Contemporary management of the neck in nasopharyngeal carcinoma

Up to 85% of the patients with nasopharyngeal carcinoma present with regional nodal metastasis. Although excellent nodal control is achieved with radiotherapy, a thorough understanding of the current TNM staging criteria and pattern of nodal spread is essential to optimize target delineation and minimize unnecessary irradiation to adjacent normal tissue. Selective nodal irradiation with sparing of the lower neck and submandibular region according to individual nodal risk is now emerging as the preferred treatment option. There has also been continual refinement in staging classification by incorporating relevant adverse nodal features. As for the uncommon occurrence of recurrent nodal metastasis after radiotherapy, surgery remains the standard of care.

[1]  R. Sun,et al.  Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence , 2020, Head & neck.

[2]  S. Liang,et al.  A Nomogram for Predicting Distant Metastasis Using Nodal-Related Features Among Patients With Nasopharyngeal Carcinoma , 2020, Frontiers in Oncology.

[3]  A. Al-Mamgani,et al.  Advances in cancer imaging require renewed radiotherapy dose and target volume concepts. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  H. Mai,et al.  Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection , 2020, Cancer biology & medicine.

[5]  De Neve Wilfried,et al.  Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Yun-bin Chen,et al.  Prognostic value of radiologic extranodal extension and its potential role in future N classification for nasopharyngeal carcinoma. , 2019, Oral oncology.

[7]  S. Liang,et al.  Prognostic value of retropharyngeal lymph node metastasis laterality in nasopharyngeal carcinoma and a proposed modification to the UICC/AJCC N staging system. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein–Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis , 2019, Therapeutic advances in medical oncology.

[9]  Jun Ma,et al.  Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients. , 2019, Oral oncology.

[10]  A. De Virgilio,et al.  Transoral robotic retropharyngeal lymph node dissection in a recurrent head and neck carcinoma , 2019, Head & neck.

[11]  Lei Liu,et al.  Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study , 2019, BMC Cancer.

[12]  L. Zeng,et al.  Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma. , 2019, Auris, nasus, larynx.

[13]  A. King,et al.  Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx. , 2019, Oral oncology.

[14]  A. Lin,et al.  Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection , 2018, The Laryngoscope.

[15]  Tae Gyu Kim,et al.  Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients , 2018, Cancer research and treatment : official journal of Korean Cancer Association.

[16]  C. Cao,et al.  Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy , 2018, Cancer research and treatment : official journal of Korean Cancer Association.

[17]  C. Terhaard,et al.  Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  A. King,et al.  Staging nodal metastases in nasopharyngeal carcinoma: which method should be used to measure nodal dimension on MRI? , 2018, Clinical radiology.

[19]  Zheng Li,et al.  Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendation , 2017, Oncotarget.

[20]  Ying Sun,et al.  Delineation of Neck Clinical Target Volume Specific to Nasopharyngeal Carcinoma Based on Lymph Node Distribution and the International Consensus Guidelines. , 2017, International journal of radiation oncology, biology, physics.

[21]  Brian O'Sullivan,et al.  International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  J. Dizon,et al.  Evidence on Effectiveness of Upper Neck Irradiation Versus Whole Neck Irradiation as Elective Neck Irradiation in Node-Negative Nasopharyngeal Cancer: A Meta-Analysis , 2016, Journal of global oncology.

[23]  He Wang,et al.  Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis , 2017, Head & neck.

[24]  Wei Zheng,et al.  Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study , 2017, Cancer medicine.

[25]  P. Khong,et al.  Cervical nodal volume for prognostication and risk stratification of patients with nasopharyngeal carcinoma, and implications on the TNM-staging system , 2017, Scientific Reports.

[26]  Chaosu Hu,et al.  The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels , 2017, Radiation Oncology.

[27]  Yiming Li,et al.  Sentinel node necrosis is a negative prognostic factor in patients with nasopharyngeal carcinoma: a magnetic resonance imaging study of 252 patients. , 2017, Current oncology.

[28]  Ying Sun,et al.  Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: Analysis of 1230 patients with positive cervical nodal metastasis , 2017, PloS one.

[29]  M. Cao,et al.  Tolerance of the Brachial Plexus to High-Dose Reirradiation. , 2017, International journal of radiation oncology, biology, physics.

[30]  J. Zöller,et al.  PET/CT surveillance versus neck dissection in advanced head and neck cancer. , 2017, Oral diseases.

[31]  Chaosu Hu,et al.  Long-term Patterns of Regional Failure for Nasopharyngeal Carcinoma following Intensity-Modulated Radiation Therapy , 2017, Journal of Cancer.

[32]  Ying Sun,et al.  Influence of Cervical Node Necrosis of Different Grades on the Prognosis of Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy , 2017, Journal of Cancer.

[33]  Hung-Ming Wang,et al.  An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy , 2017, Medicine.

[34]  N. Lee,et al.  Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma , 2017, The Laryngoscope.

[35]  P. Zhang,et al.  Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment , 2017, Head & neck.

[36]  Yangkun Luo,et al.  Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study , 2016, OncoTargets and therapy.

[37]  Zhining Yang,et al.  Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study. , 2016, The British journal of radiology.

[38]  M. Robinson,et al.  Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.

[39]  J. Kaanders,et al.  Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma. , 2016, International journal of radiation oncology, biology, physics.

[40]  J. Shah,et al.  Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy , 2016, Cancer.

[41]  C. McConkey,et al.  PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. , 2016, The New England journal of medicine.

[42]  Y. Mao,et al.  Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis , 2015, BMC Cancer.

[43]  Q. Shen,et al.  Selective neck dissection for neck residue of nasopharyngeal carcinoma: A prospective study. , 2015, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[44]  Anne W M Lee,et al.  Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  W. Wei,et al.  Salvage surgery for nasopharyngeal cancer , 2015, World journal of otorhinolaryngology - head and neck surgery.

[46]  Jianji Pan,et al.  A Comparison Between the Chinese 2008 and the 7th Edition AJCC Staging Systems for Nasopharyngeal Carcinoma , 2015, American journal of clinical oncology.

[47]  Shichuan Zhang,et al.  Level IIb CTV delineation based on cervical fascia anatomy in nasopharyngeal cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  H. Ying,et al.  Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[49]  J. Chan,et al.  Impact of nodal ratio on survival in recurrent nasopharyngeal carcinoma , 2015, Head & neck.

[50]  Ying Huang,et al.  Prognostic Value of Cervical Nodal Necrosis in Nasopharyngeal Carcinoma: Analysis of 1800 Patients with Positive Cervical Nodal Metastasis at MR Imaging. , 2015, Radiology.

[51]  L. Liao,et al.  Retrospective study of selective neck dissection versus radical neck dissection as salvage therapy for patients with recurrent nasopharyngeal squamous cell carcinoma. , 2014, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[52]  G. Shen,et al.  Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma. , 2014, The British journal of radiology.

[53]  H. Ying,et al.  Study of the medial group retropharyngeal node metastasis from nasopharyngeal carcinoma based on 3100 newly diagnosed cases. , 2014, Oral oncology.

[54]  Y. Mao,et al.  Is replacement of the supraclavicular fossa with the lower level classification based on magnetic resonance imaging beneficial in nasopharyngeal carcinoma? , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[55]  Steven J. Wang,et al.  Modified radical neck dissection for residual neck disease after radiotherapy of nasopharyngeal carcinoma. , 2014, Auris, nasus, larynx.

[56]  Yun-Fei Xia,et al.  A risk score model for the metastasis of level Ib lymph node based on the clinicopathological features of nasopharyngeal carcinoma in a large sample. , 2014, Molecular and clinical oncology.

[57]  Ying Huang,et al.  Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node–negative nasopharyngeal carcinoma , 2014, Head & neck.

[58]  Ying Sun,et al.  Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity‐modulated radiotherapy , 2014, Head & neck.

[59]  D. Li,et al.  Submandibular gland sparing in intensity-modulated radiotherapy for N0-stage nasopharyngeal carcinoma. , 2014, The British journal of radiology.

[60]  F. Feng,et al.  Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. , 2014, International journal of radiation oncology, biology, physics.

[61]  Chaosu Hu,et al.  Involvement of both Cervical Lymph Nodes and Retropharyngeal Lymph Nodes has prognostic value for N1 patients with Nasopharyngeal Carcinoma , 2014, Radiation oncology.

[62]  Quynh-Thu Le,et al.  Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[63]  J. Chen,et al.  Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma , 2014, International Journal of Clinical Oncology.

[64]  J. Chan,et al.  Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma , 2013, Head & neck.

[65]  The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients , 2013, Radiation oncology.

[66]  Ling-Ling Zhang,et al.  A randomized clinical trial comparing prophylactic upper versus whole‐neck irradiation in the treatment of patients with node‐negative nasopharyngeal carcinoma , 2013, Cancer.

[67]  Ying Sun,et al.  Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy. , 2013, International journal of radiation oncology, biology, physics.

[68]  C. Cao,et al.  Clinical characteristics and patterns of failure in the parotid region after intensity-modulated radiotherapy for nasopharyngeal carcinoma. , 2013, Oral oncology.

[69]  H. Sze,et al.  Is selective neck irradiation safe for node-negative nasopharyngeal carcinoma? , 2013, International journal of radiation oncology, biology, physics.

[70]  Q. Le,et al.  Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma. , 2013, International journal of radiation oncology, biology, physics.

[71]  J. Chan,et al.  Efficacy of fine‐needle aspiration in diagnosing cervical nodal metastasis from nasopharyngeal carcinoma after radiotherapy , 2013, The Laryngoscope.

[72]  Chaosu Hu,et al.  Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation. , 2012, Oral oncology.

[73]  Zhen Zhang,et al.  The pattern of relapse and survival of elective irradiation of the upper neck for stage N0 nasopharyngeal carcinoma , 2012, Radiation oncology.

[74]  A. Garden,et al.  Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. , 2012, The Lancet. Oncology.

[75]  Chuangzhen Chen,et al.  Long term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patients. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[76]  A. Earnest,et al.  Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence , 2012, BMC Cancer.

[77]  Y. Chan,et al.  Extracapsular lymph node spread in recurrent nasopharyngeal carcinoma , 2011, The Laryngoscope.

[78]  Yong-xue Zhu,et al.  Salvage Surgery for Neck Residue or Recurrence of Nasopharyngeal Carcinoma: A 10-Year Experience , 2010, Annals of Surgical Oncology.

[79]  H. Ying,et al.  Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma? , 2010, International journal of radiation oncology, biology, physics.

[80]  Jianji Pan,et al.  Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. , 2009, International journal of radiation oncology, biology, physics.

[81]  A. Garden,et al.  Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  S. Liang,et al.  The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma , 2009, Cancer.

[83]  H. Ying,et al.  Patterns of retropharyngeal node metastasis in nasopharyngeal carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[84]  A. G. Osborn,et al.  Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Detected by Magnetic Resonance Imaging: Prognostic Value and Staging Categories , 2009 .

[85]  David S. Shimm,et al.  Perez and Brady's Principles and Practice of Radiation Oncology , 2008 .

[86]  Ying Sun,et al.  The N Staging System in Nasopharyngeal Carcinoma with Radiation Therapy Oncology Group Guidelines for Lymph Node Levels Based on Magnetic Resonance Imaging , 2008, Clinical Cancer Research.

[87]  H. Ying,et al.  Patterns of level II node metastasis in nasopharyngeal carcinoma. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[88]  E. Vokes,et al.  Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[89]  P. Andersen,et al.  Rationale for modifying neck dissection , 2008, Journal of surgical oncology.

[90]  D. Brizel,et al.  How much radiation is the chemotherapy worth in advanced head and neck cancer? , 2007, International journal of radiation oncology, biology, physics.

[91]  W. Wei,et al.  The management of neck metastases in nasopharyngeal cancer , 2007, Current opinion in otolaryngology & head and neck surgery.

[92]  Anne W. M. Lee,et al.  N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[93]  P. Levendag,et al.  Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[94]  R. Hermans,et al.  Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[95]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[96]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[97]  J. Sham,et al.  Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy: a clinicopathological study. , 2001, Archives of otolaryngology--head & neck surgery.

[98]  L. Pierce,et al.  Definition of the supraclavicular and infraclavicular nodes: implications for three-dimensional CT-based conformal radiation therapy. , 2001, Radiology.

[99]  Jun Ma,et al.  A comparison of the Chinese 1992 and fifth‐edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma , 2000, Cancer.

[100]  H. Curtin,et al.  An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. , 1999, Archives of otolaryngology--head & neck surgery.

[101]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[102]  Y. F. Poon,et al.  Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. , 1997, Hong Kong medical journal = Xianggang yi xue za zhi.

[103]  Y. L. Chang,et al.  Salvage neck dissection for cervical recurrence of nasopharyngeal carcinoma. , 1997, Archives of otolaryngology--head & neck surgery.

[104]  Y. F. Poon,et al.  Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. , 1992, International journal of radiation oncology, biology, physics.

[105]  J Valk,et al.  Cervical lymph node metastasis: assessment of radiologic criteria. , 1990, Radiology.

[106]  W. Wei,et al.  Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma. , 1990, American journal of surgery.

[107]  D. Choy,et al.  Nasopharyngeal carcinoma: orderly neck node spread. , 1990, International journal of radiation oncology, biology, physics.

[108]  J. Ho Stage classification of nasopharyngeal carcinoma: a review. , 1978, IARC scientific publications.

[109]  D. Carr The manual for the staging of cancer. , 1977, Annals of internal medicine.

[110]  G. Fletcher Elective irradiation of subclinical disease in cancers of the head and neck , 1972, Cancer.

[111]  U. Fisch Cervical Lymphography in Cases of Laryngo-Pharyngeal Carcinoma , 1964, The Journal of Laryngology & Otology.